A new analysis raises fresh questions about the risks of the blockbuster cancer drug Avastin, suggesting the chance of dying from side effects linked to it is higher than the risk for patients on ...

– Pivotal Phase III IMbrave050 study investigating Tecentriq plus Avastin in people with early-stage hepatocellular carcinoma (HCC) at high risk of recurrence following surgery met primary endpoint of ...

Common side effects of Tecentriq when used alone include cough, decreased appetite, fatigue or weakness, nausea, and shortness of breath. Tecentriq can cause serious immune system reactions that may ...

A new study has linked Genentech's cancer drug Avastin to a higher rate of deadly side effects, the Wall Street Journal reports. The analysis, conducted by researchers at Stony Brook University ...

The combination may offer patients with recurrent, platinum-agnostic ovarian cancer a more effective, non-platinum-based treatment option. Treatment with the combination of IMGN853 (mirvetuximab ...

For women with advanced cases of ovarian cancer, the drug Avastin adds about four months to the time it takes for the cancer to worsen, according to a new report. Patients treated with Avastin in ...

The benefit obtained from Keytruda plus chemotherapy in patients with persistent, recurrent or metastatic cervical cancer occurred regardless of whether they also received Avastin. Patients with ...

(Reuters) - The U.S. Department of Veterans Affairs said it has stopped using Roche's Avastin to treat a sight-robbing eye disease as it looks into reports of increased risk of infection. Roche's ...

Results of the first clinical trial to combine two new targeted cancer drugs suggest that the combination may provide a powerful "one-two punch" against lung cancer, the nation's leading cancer killer ...

Effect of oxymatrine on the side population and expression of β-catenin in MCF-7 breast cancer cells. Background: This study evaluates patients for increased pulmonary arterial pressures when treated ...

Fatal side effects were 1.5 times more frequent among patients on Avastin plus chemotherapy than among those getting chemotherapy alone.The highest risk was seen in patients with prostate and lung ...